Transplantation Immunology
Itb-Med AB funds clinical research in renal transplantation and liver transplantation, with a strong focus on preventing graft rejection and supporting immune compatibility after organ replacement.
- Kidney transplant rejection prevention
- Liver allograft tolerance
- Allogeneic immune regulation
The sponsor’s transplant portfolio centers on immunomodulatory therapy in recipients of deceased-donor organs and other post-transplant settings.
Type 1 Diabetes
The company also supports studies in new-onset type 1 diabetes, with interest in preserving beta-cell function soon after diagnosis and in understanding immune-driven disease progression.
- Beta-cell preservation
- Early autoimmune diabetes
- Immune intervention in T1D
This area reflects a therapeutic emphasis on modifying the autoimmune process in recently diagnosed adults with type 1 diabetes.
Neurology
Itb-Med AB is active in amyotrophic lateral sclerosis research, exploring immune-targeted approaches in a progressive neurodegenerative disorder affecting motor function.
- ALS
- Neurodegenerative disease
- Motor neuron pathology
The sponsor’s neurological interest is concentrated on ALS and related mechanisms that may be influenced through immune-based treatment strategies.
